Nuchev Limited (ASX: NUC) - Share Price
- Current share price for NUC : $0.085
Nuchev Limited (NUC), an ASX-listed company, is a Company that is engaged in development, marketing and selling of Australian made Nutritional and Vitamin and Dietary Supplement products.
NUC General Information +
| ASX Code | NUC |
| Website | http://www.nuchev.com.au |
| Industry/Sector | Packaged Foods & Meats |
| Market Cap ($M) | 13 |
| NUC Share Price | $0.085 |
| Day High | $0.000 |
| Day Low | $0.000 |
| Last Close | $0.085 |
| NUC Share Price Movement | - ( No change ) |
Prices as at 16:40, 17 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Nuchev Limited (NUC) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from Nuchev Limited (NUC) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Nuchev Limited (NUC) price-sensitive announcements
NUC - Nuchev Secures Working Capital Facility
Nuchev Limited has announced the establishment of a $4 million unsecured working capital f
Nuchev Limited (NUC)
15 May 2026 | 3:24 PM
15 May 2026 | 3:24 PM
NUC - Appendix 4C and Quarterly Activities Report
Nuchev Limited, an Australian-based nutritional and wellness business, released its Append
Nuchev Limited (NUC)
27 Apr 2026 | 1:04 PM
27 Apr 2026 | 1:04 PM
NUC - Nuchev enters into Distribution Agreement with H&S
Nuchev Limited has entered into a distribution agreement with H&S Global (Au) Pty Ltd to t
Nuchev Limited (NUC)
4 Mar 2026 | 8:21 AM
4 Mar 2026 | 8:21 AM
NUC - Investor Presentation - Half Year Results to 31 Dec 25
Nuchev Limited's Half Year Results presentation for the period ending 31 December 2025 hig
Nuchev Limited (NUC)
24 Feb 2026 | 4:35 PM
24 Feb 2026 | 4:35 PM
Nuchev Limited (NUC) Recent ASX Announcements
NUC Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | -$4.08 | -$2.80 | -61.80% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$6.25 | -$7.30 | -54.40% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2023A | -$8.30 | -$16.00 | -14.70% | 0.00 | 0.00 | 0.00% | 0.0% |
NUC Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| The a2 Milk Company Limited (A2M) | $5,049M | 0.2253 | -0.1445 | 0.2605 | 26.8830 | 31.4221 | 24.9284 | 2.67% | 2.25% | 2.84% |
| Bega Cheese Limited (BGA) | $1,818M | -3.1132 | 0.0000 | 0.1754 | 0.0000 | 25.4491 | 21.6521 | 2.02% | 2.52% | 2.86% |
| Cobram Estate Olives Limited (CBO) | $1,628M | 1.6604 | 0.0000 | 0.0000 | 29.9296 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Nuchev Limited (NUC) | $13M | -0.6183 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Ricegrowers Limited (SGLLV) | $934M | -0.0114 | -0.1992 | 0.1951 | 13.3203 | 16.6341 | 13.9184 | 5.13% | 5.13% | 5.13% |
NUC Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | 1.18 | 0.00 |
| Market | 0.31 | 12.90 | 1.13 | 0.58 |
| Sector | 0.30 | 13.40 | 0.77 | 0.80 |
NUC Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Ben McFarlane Dingle | Non-Executive Chairman, Non-Executive Director | 9 Apr 2013 |
| Ms Elizabeth Smith (Liz) | Non-Executive Director | 29 Jul 2024 |
| Mr Craig Silbery | Non-Executive Director | 16 Oct 2023 |
| Mr Meng (Leo) Zhang | Non-Executive Director | 26 May 2025 |
Nuchev Limited (NUC) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 4 Dec 2025 | ZHANG, Meng (Leo) | Issued | Related Securities | 385,454 | $0.174 | $67,033.500 |
| 31 Oct 2025 | SMITH (LIZ), Elizabeth | Issued | Related Securities | 212,267 | $0.174 | $36,915.200 |
| 31 Oct 2025 | SILBERY, Craig | Issued | Related Securities | 350,990 | $0.174 | $61,040.000 |
See all changes in directors' interest & trades for Nuchev Limited (NUC) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
NUC Management
| Name | Position |
|---|---|
| Mick Myers | Chief Operating Officer and Chief Financial Officer |
| Tamara Barr | Company Secretary |
| David Curie | General Manager, Commercial |
| Roberta Barbiellini | General Manager, Practitioner |
| Helen Hovenga | Head of People and Culture |
NUC Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Nuchev Limited (NUC). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 75,567,031 (48.57%) | H&S Investment Australia Pty Ltd |
| 37,853,680 (24.33%) | Ben McFarlane Dingle |
| 12,564,873 (8.59%) | Mithaq Capital |
| 7,326,931 (5.01%) | Craig Silbery |
NUC Calendar of Events
| Date | Event |
|---|---|
| 23 February 2027 | Report (Interim) |
| 30 October 2026 | Report (Annual) |
| 27 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
